The contribution of cell phenotype to the behavior of gastric cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Several histochemical studies suggest a role of tumor cell phenotype and related differentiation markers in the prognostic assessment of gastric cancer. Unfortunately, most studies have dealt with single or a few markers and have paid limited attention to their interplay with tumor histological types, which are potentially informative of prognosis.
In this study, 292 invasive (T1b to T4) gastric cancers with prolonged follow-up and carefully analyzed histotype, inclusive of histotype-based grade, were investigated histochemically with a panel of 14 phenotypic markers known to be expressed in normal gut tissues and gastric cancer.
Three of seven intestinal type markers investigated showed a trend for improved prognosis, one of which, CDX2, was stage independent. Three among gastric and pancreatobiliary duct markers (MUC1, MUC6, and pepsinogen II), predicted more severe prognosis stage independently, as did a combination of eight potentially informative (p < 0.1 at univariable Cox analysis) markers. Cancers with predominantly intestinal phenotype had significantly better prognosis than those with predominantly gastric, mixed, or poorly defined phenotypes; among the latter, those with high lymphocyte response, with favorable outcome, were separated from anaplastic cancers, with ominous prognosis. At multivariable analysis, CDX2 and the eight marker combination proved to be stage- and grade-independent predictors.
When individually considered, and with the exception of CDX2, the biomarkers investigated gave an appreciable, although moderate, contribution to the prognostic evaluation of gastric cancer. Combined analysis of all potentially informative markers gave more important information, highly additive to both stage and histotype-based grade.
- Fiocca R, Villani L, Tenti P, Solcia E, Cornaggia M, Frigerio B, et al. Characterization of four main cell types in gastric cancer: foveolar, mucopetic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of “early” and “advanced” tumours. Pathol Res Pract. 1987;182:308–25. CrossRef
- Machado JC, Nogueira AMM, Carneiro F, Reis CA, Sobrinho-Simões M. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TTF1 and TTF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 2000;190:437–43. CrossRef
- Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61:212–20. CrossRef
- Fiocca R, Villani L, Tenti P, Cornaggia M, Finzi G, Riva C, et al. The foveolar cell component of gastric cancer. Hum Pathol. 1990;21:260–70. CrossRef
- Bara J, Chastre E, Mahiou J, Singh RL, Forgue-Lafitte ME, Hollande E, et al. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer. 1998;75:767–73. CrossRef
- Fiocca R, Villani L, Tenti P, Cornaggia M, Finzi G, Capella C, et al. Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopy study using BD-5 monoclonal antibody. J Clin Pathol. 1988;41:178–87. CrossRef
- Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res. 1998;4:2605–14.
- Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5 and MUC6 expressions in gastric carcinomas. Cancer (Phila). 2001;92:1427–34. CrossRef
- Fiocca R, Cornaggia M, Villani L, Capella C, Solcia E, Samloff M. Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases. Cancer (Phila). 1988;61:956–62. CrossRef
- Sato Y, Itoh F, Hinoda Y, Ohe Y, Nakagawa N, Ueda R, et al. Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol. 1996;31:12–7. CrossRef
- Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, et al. Expression of Cdx2 and the phenotype of advanced gastric cancers. Relationship with prognosis. J Cancer Res Clin Oncol. 2003;129:727–34. CrossRef
- Kim MA, Lee HS, Yang H-K, Kim WH. Cytokeratin expression profile in gastric carcinomas. Hum Pathol. 2004;5:576–81. CrossRef
- Park SS, Kang SH, Park JM, Kim JH, Oh SC, Lee JH, et al. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively? Ann Surg Oncol. 2007;14:94–9. CrossRef
- Laurén P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
- Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003;14:3208–15. CrossRef
- Tan IB, Ivanova T, Lim KH, Ong CW, Deng N, Lee J, et al. Intrinsic subtypes of gastric cancers, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology. 2011;141:476–85. CrossRef
- Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer (Phila). 2000;89:724–32. CrossRef
- Han HS, Lee SY, Lee KY, Hong SN, Kim JH, Sung IK, et al. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness. J Gastroenterol Hepatol. 2008;24:658–66. CrossRef
- Minamoto T, Mai M, Watanabe K, Ooi A, Kitamura T, Takahashi Y, et al. Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor. Cancer (Phila). 1990;66(5):945–52. CrossRef
- Grogg KL, Lohse CM, Pankratz VS, Halling KC, Smyrk TC. Lymphocyte-rich gastric cancer: associations with Epstein–Barr virus, microsatellite instability, histology, and survival. Mod Pathol. 2003;16:641–51. CrossRef
- Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H. Well differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol. 1999;30:826–32. CrossRef
- Solcia E, Luinetti O, Tava F, Klersy C, Grillo F, Pandolfo N, et al. Identification of a lower grade muconodular subtype of gastric mucinous cancer. Virchows Arch. 2004;445:572–9. CrossRef
- Chiaravalli AM, Klersy C, Tava F, Manca R, Fiocca R, Capella C, et al. Lower- and higher-grade subtypes of diffuse gastric cancer. Hum Pathol. 2009;40:1591–9. CrossRef
- Rossi E, Klersy C, Manca R, Zuffardi O, Solcia E. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer. Hum Pathol. 2011;42:1937–45. CrossRef
- Solcia E, Klersy C, Mastracci L, Alberizzi P, Candusso ME, Diegoli M, et al. A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch. 2009;455:197–211. CrossRef
- Chiaravalli A, Klersy C, Vanoli A, Ferretti A, Capella C, Solcia E. Histotype-based prognostic classification of gastric cancer. World J Gastroenterol. 2012;18(9):896–904. CrossRef
- Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer. 1998;1:10–24. CrossRef
- Lauwers GY, Carneiro F, Graham DY, Curado MP, Franceschi S, Montgomery E et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC; 2010.
- Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al. ECL cell tumour and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–42. CrossRef
- Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358:2107–16. CrossRef
- Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. Colorectal cancer in mice genetically deficient in the mucin MUC2. Science. 2002;295(5560):1726–9. CrossRef
- Bai YQ, Miyake S, Iwai T, Yuasa Y. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1(CIP1 gene). Oncogene. 2003;22:5998–6005. CrossRef
- Guo R-J, Funakoshi S, Lee HH, Kong J, Lynch JP. The intestine-specific transcription factor Cdx2 inhibits β-catenin-TCF protein complex. Carcinogenesis (Oxf). 2010;31:159–66. CrossRef
- Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. Br J Cancer. 2004;91:1342–8. CrossRef
- Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control on the cell surface. Cancer (Phila). 2004;4:45–59.
- Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S, et al. MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling. Nat Cell Biol. 2007;9:1419–27. CrossRef
- Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, et al. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology. 2010;139:213–25. CrossRef
- Bennett K, Levine T, Ellis JS, Peanasky RJ, Samloff IM, Kay J, et al. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol. 1992;22:1519–24. CrossRef
- Finzi G, Cornaggia M, Capella C, Fiocca R, Bosi F, Solcia E, et al. Cathepsin E in follicole-associated epithelium of intestine and tonsils. Its localization to M cells and possible role in antigen processing. Histochemistry. 1993;99:201–11. CrossRef
- Yee CS, Yao Y, Li P, Klemsz MJ, Blum JS, Chang C-H. Cathepsin E: a novel target for regulation by class II transactivator. J Immunol. 2004;172:5528–34.
- Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia E. Epithelial cytotoxicity, immune response, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol. 1994;29(suppl 205):11–21. CrossRef
- The contribution of cell phenotype to the behavior of gastric cancer
Volume 16, Issue 4 , pp 462-471
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Tumor cell phenotype
- Phenotypic markers
- Gastric cancer
- Industry Sectors
- Author Affiliations
- 1. Department of Pathology, University of Pavia, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, 27100, Pavia, Italy
- 2. Biometry and Statistics Unit, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy
- 3. Department of Pathology, University of Genova, IRCCS Azienda Ospedaliera Universitaria San Martino IST, Via De Toni 14, 16132, Genova, Italy